Cargando…

Inflammation in prostate cancer progression and therapeutic targeting

Chronic inflammation contributes to the onset and progression of human cancer, via modifications in the tumor microenvironment by remodeling the extracellular matrix (ECM) and initiating epithelial mesenchymal transition (EMT). At the biological level, chronically inflamed cells release cytokines th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stark, Timothy, Livas, Lydia, Kyprianou, Natasha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708587/ https://www.ncbi.nlm.nih.gov/pubmed/26816843 http://dx.doi.org/10.3978/j.issn.2223-4683.2015.04.12

Ejemplares similares

Inflammation as a Driver of Prostate Cancer Metastasis and Therapeutic Resistance
por: Archer, Maddison, et al.
Publicado: (2020)

Profiling Prostate Cancer Therapeutic Resistance
por: Wade, Cameron A., et al.
Publicado: (2018)

Androgen Receptor as a Driver of Therapeutic Resistance in Advanced Prostate Cancer
por: Kahn, Barbara, et al.
Publicado: (2014)

Epithelial mesenchymal transition (EMT) in prostate growth and tumor progression
por: Grant, Campbell M., et al.
Publicado: (2013)

Exosomes as A Next-Generation Diagnostic and Therapeutic Tool in Prostate Cancer
por: Gaglani, Simita, et al.
Publicado: (2021)

Mechanisms navigating the TGF-β pathway in prostate cancer
por: Cao, Zheng, et al.
Publicado: (2015)

Non-Coding RNAs Set a New Phenotypic Frontier in Prostate Cancer Metastasis and Resistance
por: Altschuler, Joshua, et al.
Publicado: (2021)

Emerging biomarkers of prostate cancer (Review)
por: MARTIN, SARAH K., et al.
Publicado: (2012)

Deciphering Evolutionary Dynamics and Lineage Plasticity in Aggressive Prostate Cancer
por: Kyprianou, Natasha, et al.
Publicado: (2021)

Prostate tumor neuroendocrine differentiation via EMT: The road less traveled
por: Dicken, Haley, et al.
Publicado: (2019)

Prognostic value of inflammation in prostate cancer progression and response to therapeutic: a critical review
por: Sciarra, Alessandro, et al.
Publicado: (2016)

Novel Pharmacologic Targeting of Tight Junctions and Focal Adhesions in Prostate Cancer Cells
por: Hensley, Patrick J., et al.
Publicado: (2014)

A tale of two trials: The impact of 5α-reductase inhibition on prostate cancer (Review)
por: LACY, JOHN M., et al.
Publicado: (2014)

Epigenetic mechanisms underlying subtype heterogeneity and tumor recurrence in prostate cancer
por: Chakraborty, Goutam, et al.
Publicado: (2023)

Circadian Rhythm Disruption as a Contributor to Racial Disparities in Prostate Cancer
por: Dasari, Sonali S., et al.
Publicado: (2022)

Anoikis in phenotypic reprogramming of the prostate tumor microenvironment
por: Nepali, Prerna R., et al.
Publicado: (2023)

The Promise of Novel Molecular Markers in Bladder Cancer
por: Miremami, Jahan, et al.
Publicado: (2014)

Immune Inflammation Pathways as Therapeutic Targets to Reduce Lethal Prostate Cancer in African American Men
por: Kiely, Maeve, et al.
Publicado: (2021)

Association between Expression of Connective Tissue Genes and Prostate Cancer Growth and Progression
por: Treacy, Patrick-Julien, et al.
Publicado: (2023)

Epigenetic modulators as therapeutic targets in prostate cancer
por: Graça, Inês, et al.
Publicado: (2016)

Linking obesogenic dysregulation to prostate cancer progression
por: Taylor, Renea A, et al.
Publicado: (2015)

Inflammation as a Therapeutic Target in Cancer Cachexia
por: Clamon, Gerald, et al.
Publicado: (2022)

Gender Differences in Urothelial Bladder Cancer: Effects of Natural Killer Lymphocyte Immunity
por: Lutz, Charles T., et al.
Publicado: (2021)

Clinical Significance of Extracellular Vesicles in Prostate and Renal Cancer
por: Chen, Tzu-Yi, et al.
Publicado: (2023)

Transcription Factors as Novel Therapeutic Targets and Drivers of Prostate Cancer Progression
por: Xie, Kangzhe, et al.
Publicado: (2022)

Therapeutic Approaches Targeting MYC-Driven Prostate Cancer
por: Rebello, Richard J., et al.
Publicado: (2017)

Mechanisms of Prostate Cancer Cells Survival and Their Therapeutic Targeting
por: Pejčić, Tomislav, et al.
Publicado: (2023)

Therapeutical Targets in Allergic Inflammation
por: Salvati, Lorenzo, et al.
Publicado: (2022)

KRAS mutant lung cancer: progress thus far on an elusive therapeutic target
por: Bhattacharya, Saveri, et al.
Publicado: (2015)

Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis
por: Yan, Yiwu, et al.
Publicado: (2022)

Therapeutic Rationales, Progresses, Failures, and Future Directions for Advanced Prostate Cancer
por: Wadosky, Kristine M, et al.
Publicado: (2016)

Chromatin and Epigenetic Dysregulation of Prostate Cancer Development, Progression, and Therapeutic Response
por: Kukkonen, Konsta, et al.
Publicado: (2021)

Molecular Signatures in Urologic Tumors
por: Larkin, Spencer, et al.
Publicado: (2013)

Reversion of epithelial-mesenchymal transition by a novel agent DZ-50 via IGF binding protein-3 in prostate cancer cells
por: Cao, Zheng, et al.
Publicado: (2017)

Impact of COVID-19 on Prostate Cancer Management: Guidelines for Urologists
por: Dovey, Zachary, et al.
Publicado: (2020)

Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
por: Chakravarty, Dimple, et al.
Publicado: (2020)

Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles
por: Hoang, David T, et al.
Publicado: (2016)

Exploring the Wnt Pathway as a Therapeutic Target for Prostate Cancer
por: Koushyar, Sarah, et al.
Publicado: (2022)

The significance of dynamin 2 expression for prostate cancer progression, prognostication, and therapeutic targeting
por: Xu, Bin, et al.
Publicado: (2014)

Cancer-Associated Fibroblast: Role in Prostate Cancer Progression to Metastatic Disease and Therapeutic Resistance
por: Bedeschi, Martina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s8o7jn11suj8lmdh76htignjig